Outcomes of abdominal aortic aneurysm repairs: Endovascular vs open surgical repairs.


Journal

Asian journal of surgery
ISSN: 0219-3108
Titre abrégé: Asian J Surg
Pays: Netherlands
ID NLM: 8900600

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 07 05 2021
revised: 29 05 2021
accepted: 08 06 2021
pubmed: 2 7 2021
medline: 6 1 2022
entrez: 1 7 2021
Statut: ppublish

Résumé

Operative mortality after endovascular aneurysm repair (EVAR) has been reported as lower than open surgical repair (OSR) for abdominal aortic aneurysm (AAA) in randomized controlled trials. However, many cohort studies have demonstrated similar mortality rates for both procedures. We compared operative mortality between EVAR and OSR, at our institution. All AAA operations from 2012 to 2017 were reviewed, and baseline characteristics were collected. Outcomes included 30-day mortality, operative data, complications, length of hospital stay (LOS), costs, re-intervention, and survival rates were compared. A multivariable analysis with unbalanced characteristics was performed. We had a total of 162 patients, 100 having OSR and 62 for EVAR. The EVAR group was older, with higher ASA classification. Thirty-day mortality rate did not significantly differ (0/100 for OSR and 2/62 (3%) for EVAR; p = 0.145), while the EVAR group had less blood loss, shorter operative times, and LOS, but higher re-intervention rates (adjusted hazard ratio 6.4 (95%CI: 1.4, 26.8)). Survival rates did not significantly differ between the groups. EVAR cost approximately 1-million yen more. OSR had low 30-day mortality rate in selected low-risk patients whereas EVAR had less blood loss, shorter operative times, LOS and could be done in high-risk patients with low 30-day mortality but with higher re-intervention rate.

Sections du résumé

BACKGROUND BACKGROUND
Operative mortality after endovascular aneurysm repair (EVAR) has been reported as lower than open surgical repair (OSR) for abdominal aortic aneurysm (AAA) in randomized controlled trials. However, many cohort studies have demonstrated similar mortality rates for both procedures. We compared operative mortality between EVAR and OSR, at our institution.
METHODS METHODS
All AAA operations from 2012 to 2017 were reviewed, and baseline characteristics were collected. Outcomes included 30-day mortality, operative data, complications, length of hospital stay (LOS), costs, re-intervention, and survival rates were compared. A multivariable analysis with unbalanced characteristics was performed.
RESULTS RESULTS
We had a total of 162 patients, 100 having OSR and 62 for EVAR. The EVAR group was older, with higher ASA classification. Thirty-day mortality rate did not significantly differ (0/100 for OSR and 2/62 (3%) for EVAR; p = 0.145), while the EVAR group had less blood loss, shorter operative times, and LOS, but higher re-intervention rates (adjusted hazard ratio 6.4 (95%CI: 1.4, 26.8)). Survival rates did not significantly differ between the groups. EVAR cost approximately 1-million yen more.
CONCLUSIONS CONCLUSIONS
OSR had low 30-day mortality rate in selected low-risk patients whereas EVAR had less blood loss, shorter operative times, LOS and could be done in high-risk patients with low 30-day mortality but with higher re-intervention rate.

Identifiants

pubmed: 34193387
pii: S1015-9584(21)00355-9
doi: 10.1016/j.asjsur.2021.06.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-352

Informations de copyright

Copyright © 2021. Published by Elsevier Taiwan LLC.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors disclosed no conflict of interests.

Auteurs

Boonying Siribumrungwong (B)

Division of Vascular and Endovascular Surgery, Department of Surgery, Thammasat University Hospital, Pathum Thani, Thailand; Center of Excellence in Applied Epidemiology, Thammasat University, Thailand. Electronic address: Boonying22@gmail.com.

Jiro Kurita (J)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Tatsuo Ueda (T)

Department of Radiology, Nippon Medical School Hospital, Tokyo, Japan.

Daisuke Yasui (D)

Department of Radiology, Nippon Medical School Hospital, Tokyo, Japan.

Ken-Ichiro Takahashi (KI)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Takashi Sasaki (T)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Yasuo Miyagi (Y)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Shun-Ichiro Sakamoto (SI)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Yosuke Ishii (Y)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Tetsuro Morota (T)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Takashi Nitta (T)

Department of Cardiovascular Surgery, Nippon Medical School Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH